Pharmaceutical Information |
Drug Name |
Carbachol |
Drug ID |
BADD_D00355 |
Description |
Carbamoylcholine, also known as carbachol, is a muscarinic agonist discovered in 1932.[A226315] Carbamoylcholine was initially used as a treatment for migraines,[A226365] induction of diuresis,[A226370] and other parasympathetic effects.
Carbamoylcholine was granted FDA approval on 28 September 1972.[L30245] |
Indications and Usage |
Carbamoylcholine is indicated to induce miosis for surgery and to reduce intraocular pressure elevations in the first 24 hours after cataract surgery.[L30245] |
Marketing Status |
approved |
ATC Code |
N07AB01; S01EB02 |
DrugBank ID |
DB00411
|
KEGG ID |
D00524
|
MeSH ID |
D002217
|
PubChem ID |
5831
|
TTD Drug ID |
D0U7BW
|
NDC Product Code |
65732-131; 0065-0023 |
UNII |
8Y164V895Y
|
Synonyms |
Carbachol | Carbocholine | Carbacholine | Miostat | Jestryl | Carbamann | Doryl | Carbastat | Carboptic | Isopto Carbachol | Carbachol, Isopto | Carbamylcholine | Carbamoylcholine |
|
Chemical Information |
Molecular Formula |
C6H15N2O2.Cl |
CAS Registry Number |
51-83-2 |
SMILES |
C[N+](C)(C)CCOC(=O)N.[Cl-] |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|